Avanos
Avanos Medical (NYSE: AVNS) is a global medical device company that develops and sells chronic pain (COOLIEF RF ablation), enteral feeding (MIC-KEY, CORFLO, CORTRAK) and post-operative recovery (Game Ready, ANCORIS) products to hospitals, clinicians and home-care patients across 90+ countries.
- Company typePublic
- Founded-
- HeadquartersChatswood, Australia
- Headcount—
- GTM typeB2B
- OfferingHardware or Manufacturing
What Avanos does
Avanos Medical is a publicly traded (NYSE: AVNS) medical device company that develops, manufactures and commercialises clinical products in three core franchises: chronic pain management via the COOLIEF cooled radiofrequency ablation system, enteral feeding via the MIC-KEY and CORFLO portfolios together with the CORTRAK 2 electromagnetic placement system, and post-operative/injury recovery via Game Ready cryocompression and ANCORIS surgical site dressings. Its technology is built around proprietary radiofrequency and electromagnetic sensing platforms, with COOLIEF positioned as the only FDA-cleared non-nerve ablating cooled RF technology and CORTRAK 2 enabling radiation-free real-time feeding tube placement at the bedside. The MIC-KEY low-profile gastrostomy tube has been marketed for over 30 years, signalling a long-established enteral franchise.
The company operates a multi-channel B2B medical device go-to-market, selling through direct sales, regional manufacturer representatives, and — in Australia — through the NDIS provider network to disability participants, as well as through healthcare facilities for acute and procedural use. Avanos serves hospitals, pain clinics, neonatal/paediatric and adult home enteral patients, sports medicine and orthopaedic practices, and post-surgical care settings. Its commercial reach spans 90+ countries, with regional offices across APAC (Singapore, Tokyo, Gurgaon, Mumbai, Seoul, Shanghai, Taipei) and an Australian subsidiary headquartered in Chatsworth/Chatswood, NSW (Avanos Medical Australia Pty Ltd). Revenue mechanics are not disclosed in the supplied material, but the public-market status and global footprint are consistent with a multi-hundred-million-dollar enterprise.
Avanos firmographics
Firmographics- Name
- Avanos
- Legal name
- Avanos Medical, Inc.
- Website
- https://avanos.com.au
- Company type
- Public
- Operating status
- Operating
- Short description
- Avanos Medical (NYSE: AVNS) is a global medical device company that develops and sells chronic pain (COOLIEF RF ablation), enteral feeding (MIC-KEY, CORFLO, CORTRAK) and post-operative recovery (Game Ready, ANCORIS) products to hospitals, clinicians and home-care patients across 90+ countries.
- Ownership category
- akta.pro rank
Avanos industry classification
Industry- Product category
- Medical Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Endoscopic Therapeutic & Access Devices (Trocars, dilators, biopsy/ablation tools) (HLAHADAN)
Keywords
Where Avanos is headquartered
LocationHeadquarters
- HQ city
- Chatswood
- HQ country
- Australia
- HQ region
- Oceania
Offices6 records
Markets served
Avanos business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
Revenue model
- Medical Device Sales: Sale of medical devices including enteral feeding tubes, radiofrequency ablation systems, and cryocompression products. Products are sold directly to healthcare facilities and through distributors. Revenue is generated through one-time device sales and recurring accessory/replacement product sales.
- NDIS Funded Products: Enteral feeding products are funded through Australia's National Disability Insurance Scheme (NDIS), with approved providers supplying Avanos products to eligible participants.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Monthly | Contact Sales - No public pricing available |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels9 records
Avanos product offering
Product offeringCore offering
Avanos Medical, Inc. develops, manufactures, and markets specialty medical devices across three portfolios: (1) Chronic Pain Management — water-cooled and standard radiofrequency ablation systems and probes (COOLIEF*, AVANOS CRG generator) for nerve denervation; (2) Digestive Health — enteral feeding tubes, accessories, and placement/securement systems (MIC*, MIC-KEY*, CORFLO*, CORTRAK* 2 EAS, FARRELL*, ANCORIS*, CORGRIP*); and (3) Recovery — Game Ready* cryocompression therapy systems for post-operative and injury recovery. Products are sold globally in more than 90 countries to healthcare professionals and facilities.
Product overview
Avanos is a medical device company offering a portfolio of healthcare solutions organized into three main categories: Chronic Pain Management (COOLIEF* Cooled Radiofrequency and standard Radiofrequency ablation systems for nerve denervation), Digestive Health (enteral feeding tubes and accessories including MIC*, MIC-KEY*, CORFLO* brands, CORTRAK* 2 navigation system, FARRELL* Valve decompression system, and ANCORIS* tube anchor), and Recovery (Game Ready* cryocompression therapy). The products range from capital equipment (RF generators) to disposable medical devices (feeding tubes, RF probes) and work across the care continuum from hospital to home settings.
Differentiator
Problem solved
Functional benefit
Brands
- MIC-KEY*: Low-profile balloon-retained gastrostomy feeding tubes for enteral nutrition delivery
- MIC*
- CORTRAK*
- CORFLO*
- FARRELL*
- ANCORIS*
- CORGRIP*
- COOLIEF*
- Game Ready*
Quantifiable outcome
- Up to 24 months of pain relief with improved physical function and reduced drug utilization from COOLIEF* Cooled RF treatment
- +3 more outcomes
Companies that use Avanos
Customer profileNamed customers2 records
Segments4 records
Avanos technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Avanos partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- NDIS Registered Providers NetworkcoreAvanos products are distributed through a network of NDIS registered providers across Australia and New Zealand. Providers include Alpha Medical, Australian Home Nursing Supplies, BrightSky, Clifford Hallam Healthcare, Independence Australia, Silver Chain, and approximately 30+ other approved distributors. These providers supply enteral feeding products to NDIS participants under their funded plans.
Scale indicators2 records
Recent moves1 record
Expansion highlights5 records
Avanos competitors and assessment
Company assessmentDirect peers
- Teleflex: Direct peer in enteral feeding devices (e.g., NEO-TECH, Kangaroo) and surgical instruments. Overlaps with Avanos in NICU/pediatric feeding tubes and general surgical/cannula products used in interventional procedures.
- Medtronic: Largest medical-device incumbent in interventional pain (RF ablation, spinal cord stimulation, targeted drug delivery) and a global enteral/patient-care franchise. Directly competes with Avanos across both chronic pain and digestive health, with materially larger R&D and sales scale.
- Boston Scientific: Direct competitor in RF ablation and interventional pain management, with overlapping call points in interventional radiology and pain medicine. Its Vertiflex (now part of Boston Scientific) and spinal-cord-stimulation portfolio competes head-to-head with COOLIEF* and standard RF products.
- ICU Medical: Medical-device company focused on IV infusion, oncology and enteral feeding products with overlapping clinical call points (nursing, ICU, nutrition support). Comparable in scale and channel to Avanos' digestive-health business.
- Convatec: Public medtech focused on ostomy, continence, advanced wound care and enteral feeding. Directly competes with Avanos' MIC-KEY* and CORFLO* franchises in enteral nutrition delivery, particularly in home and long-term care channels.
- Nevro Corp: Pure-play interventional pain competitor with HF10 high-frequency spinal cord stimulation. Competes against Avanos in the chronic-pain armamentarium and increasingly in the same pain-physician call point targeted by COOLIEF*.
- Vygon: European-headquartered single-use medical-device specialist with a meaningful enteral feeding and NICU portfolio (e.g., Nutrisafe, EnFit ranges). Comparable in enteral feeding product mix and hospital-channel focus to Avanos' digestive-health business.
Broad incumbents
- Stryker: Broad medical-device incumbent with significant orthopedic and surgical-instruments presence and an interventional pain/spine portfolio (including Vertiflex via acquisition). Competes with Avanos in pain management and adjacent OR/surgical-instrument categories.
- Abbott Laboratories: Diversified medical-device leader with neuromodulation (spinal cord stimulation, DRG therapy) competing against COOLIEF*, plus enteral nutrition products (e.g., PediaSure, Vital) overlapping with Avanos' digestive-health patient base.
Emerging players
- Penumbra: Interventional neurovascular and peripheral vascular device company with growing presence in interventional pain (real-time imaging, thrombectomy, neurovascular access). Adjacent competitor in procedure-driven chronic-pain and vascular access categories where Avanos' CORTRAK* tracking technology also operates.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Avanos social profiles
Digital presenceAvanos financial estimates
Financial estimateRevenue estimate
Valuation estimate
Avanos leadership team
Management profileNumber of profiles
Avanos subsidiaries and ownership
Company hierarchySubsidiaries10 records
Avanos funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Avanos M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Avanos
What does Avanos do?
Avanos Medical, Inc. develops, manufactures, and markets specialty medical devices across three portfolios: (1) Chronic Pain Management — water-cooled and standard radiofrequency ablation systems and probes (COOLIEF*, AVANOS CRG generator) for nerve denervation; (2) Digestive Health — enteral feeding tubes, accessories, and placement/securement systems (MIC*, MIC-KEY*, CORFLO*, CORTRAK* 2 EAS, FARRELL*, ANCORIS*, CORGRIP*); and (3) Recovery — Game Ready* cryocompression therapy systems for post-operative and injury recovery. Products are sold globally in more than 90 countries to healthcare professionals and facilities.
Is Avanos a public or private company?
Avanos is a public company. It is currently operating.
When was Avanos founded?
Avanos was founded in -1.
Where is Avanos based?
Avanos is headquartered in Chatswood, Australia, in the Oceania region.
How does Avanos make money?
Two revenue lines are on record. Medical Device Sales are the primary driver. The others are NDIS Funded Products.
Who are Avanos's main competitors?
Direct peers on record are Teleflex, Medtronic, Boston Scientific, ICU Medical, Convatec, Nevro Corp and Vygon. Broad incumbents are Stryker and Abbott Laboratories. Penumbra is listed as an emerging player.
Does Avanos have an API?
No public API is recorded for Avanos.
What industry is Avanos in?
Avanos's product category is Medical Devices. Its primary akta.pro industry code is HLAHADAN, Endoscopic Therapeutic & Access Devices (Trocars, dilators, biopsy/ablation tools). Its NAICS code is 334510 and its SIC code is 3841.